{
  "page": 5,
  "value": [
    {
      "path": "_news/2021-12-23-4-internet-of-medical-things-iomt-stocks-to-buy-for-2022.md",
      "title": "4 Internet of Medical Things (IoMT) Stocks to Buy for 2022",
      "excerpt": "The Internet of Medical Things (IoMT) is swiftly gaining pace as healthcare companies are looking for ways to innovate and keep up with technology to help patients and physicians better monitor and track diseases.",
      "sourceUrl": null,
      "webUrl": "https://www.nasdaq.com/articles/4-internet-of-medical-things-iomt-stocks-to-buy-for-2022",
      "originalUrl": "https://www.nasdaq.com/articles/4-internet-of-medical-things-iomt-stocks-to-buy-for-2022",
      "featuredContent": null,
      "highlight": null,
      "heat": null,
      "tags": null,
      "images": null,
      "content": "\r\n",
      "type": "article",
      "ampWebUrl": "https://www.nasdaq.com/articles/4-internet-of-medical-things-iomt-stocks-to-buy-for-2022?amp",
      "cdnAmpWebUrl": "https://www-nasdaq-com.cdn.ampproject.org/c/s/www.nasdaq.com/articles/4-internet-of-medical-things-iomt-stocks-to-buy-for-2022?amp",
      "publishedDateTime": "2021-12-23T04:28:00-08:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Nasdaq",
        "domain": "nasdaq.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "AI in Healthcare",
        "AI"
      ]
    },
    {
      "path": "_news/2021-12-21-avodahmeds-human-centered-artificial-intelligence-focuses-on-primary-care-in-2022.md",
      "title": "AvodahMed’s Human-Centered Artificial Intelligence Focuses on Primary Care in 2022",
      "excerpt": "With the arrival of 2022 imminent, Avodah, a transformative SaaS company powering artificial intelligence (AI) capabilities, and its healthcare division AvodahMed are using new capital to extend its digital health services to primary care.",
      "sourceUrl": null,
      "webUrl": "https://www.valdostadailytimes.com/news/business/avodahmed-s-human-centered-artificial-intelligence-focuses-on-primary-care-in-2022/article_f467a092-1dcf-50e5-96a7-cc7506c6c4ec.html",
      "originalUrl": "https://www.valdostadailytimes.com/news/business/avodahmed-s-human-centered-artificial-intelligence-focuses-on-primary-care-in-2022/article_f467a092-1dcf-50e5-96a7-cc7506c6c4ec.html",
      "featuredContent": null,
      "highlight": null,
      "heat": null,
      "tags": null,
      "images": [
        {
          "url": "https://static.cnhionline.com/ksherman/images/rtj_ad.gif",
          "width": 300,
          "height": 250,
          "title": null,
          "attribution": null,
          "isCached": true
        }
      ],
      "content": "\r\n",
      "type": "article",
      "ampWebUrl": null,
      "cdnAmpWebUrl": null,
      "publishedDateTime": "2021-12-21T04:01:00-08:00",
      "updatedDateTime": null,
      "provider": {
        "name": "The Valdosta Daily Times",
        "domain": "valdostadailytimes.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "AI in Healthcare",
        "AI"
      ]
    },
    {
      "path": "_news/2021-12-21-visually-impaired-persons-try-their-hand-at-offering-massage-therapy.md",
      "title": "Visually impaired persons try their hand at offering massage therapy",
      "excerpt": "Massage therapy business is among the most affected businesses as it was restricted severally yet the business has been increasingly viable for visually impaired people. Beth Gatonye, founder of Seeing Hands Rwanda- an organization aimed to improve the social and economic wellbeing of people with visual impairments-said that she runs a massage therapy centre that employs visually impaired people but where operations were severely affected following the Covid-19 pandemic times.",
      "sourceUrl": null,
      "webUrl": "https://www.newtimes.co.rw/business/visually-impaired-persons-try-their-hand-offering-massage-therapy",
      "originalUrl": "https://www.newtimes.co.rw/business/visually-impaired-persons-try-their-hand-offering-massage-therapy",
      "featuredContent": null,
      "highlight": null,
      "heat": null,
      "tags": null,
      "images": [
        {
          "url": "https://www.newtimes.co.rw/sites/default/files/main/articles/2021/12/21/beth.jpg",
          "width": 847,
          "height": 491,
          "title": null,
          "attribution": null,
          "isCached": true
        }
      ],
      "content": "\r\n",
      "type": "article",
      "ampWebUrl": null,
      "cdnAmpWebUrl": null,
      "publishedDateTime": "2021-12-20T23:10:00-08:00",
      "updatedDateTime": null,
      "provider": {
        "name": "The New Times",
        "domain": "newtimes.co.rw",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "AI in Healthcare",
        "AI"
      ]
    },
    {
      "path": "_news/2021-12-21-data-hunters-will-be-big-pharmas-next-prey.md",
      "title": "Data hunters will be Big Pharma’s next prey",
      "excerpt": "Big Pharma will need to tool up in the data arms race. Drug giants like AstraZeneca are pouring $160 billion a year into unearthing new treatments. Artificial intelligence could provide a shortcut, by helping discover new treatments and getting them to market sooner.",
      "sourceUrl": null,
      "webUrl": "https://www.reuters.com/breakingviews/data-hunters-will-be-big-pharmas-next-prey-2021-12-20/",
      "originalUrl": "https://www.reuters.com/breakingviews/data-hunters-will-be-big-pharmas-next-prey-2021-12-20/",
      "featuredContent": null,
      "highlight": null,
      "heat": null,
      "tags": null,
      "images": [
        {
          "url": "https://www.reuters.com/resizer/4_2o1OYU28UCWef805L8u61FYCA=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/BSX22HO5WNJ4ZMOPMNCLSEDGHU.jpg",
          "width": 1200,
          "height": 628,
          "title": null,
          "attribution": null,
          "isCached": true
        }
      ],
      "content": "\r\n",
      "type": "article",
      "ampWebUrl": null,
      "cdnAmpWebUrl": null,
      "publishedDateTime": "2021-12-20T18:40:00-08:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Reuters",
        "domain": "reuters.com",
        "images": [
          {
            "url": "https://everyday-cc.github.io/ai/assets/images/organizations/reuters.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null,
            "isCached": false
          }
        ],
        "publishers": null,
        "authors": null
      },
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "AI in Healthcare",
        "AI"
      ]
    },
    {
      "path": "_news/2021-12-20-data-hunters-will-be-big-pharmas-next-prey.md",
      "title": "Data hunters will be Big Pharma’s next prey",
      "excerpt": "Big Pharma will need to tool up in the data arms race. Drug giants like AstraZeneca are pouring $160 billion a year into unearthing new treatments. Artificial intelligence could provide a shortcut, by helping discover new treatments and getting them to market sooner.",
      "sourceUrl": null,
      "webUrl": "https://www.reuters.com/article/us-pharmaceuticals-m-a-breakingviews-idDEKBN2IZ0YW",
      "originalUrl": "https://www.reuters.com/article/us-pharmaceuticals-m-a-breakingviews-idDEKBN2IZ0YW",
      "featuredContent": null,
      "highlight": null,
      "heat": null,
      "tags": null,
      "images": [
        {
          "url": "https://s2.reutersmedia.net/resources/r/?m=02&d=20211220&t=2&i=1585312285&w=&fh=545px&fw=&ll=&pl=&sq=&r=LYNXMPEHBJ0F3",
          "width": 818,
          "height": 545,
          "title": null,
          "attribution": null,
          "isCached": true
        }
      ],
      "content": "\r\n",
      "type": "article",
      "ampWebUrl": "https://mobile.reuters.com/article/amp/idDEKBN2IZ0YW",
      "cdnAmpWebUrl": "https://mobile-reuters-com.cdn.ampproject.org/c/s/mobile.reuters.com/article/amp/idDEKBN2IZ0YW",
      "publishedDateTime": "2021-12-20T02:33:00-08:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Reuters",
        "domain": "reuters.com",
        "images": [
          {
            "url": "https://everyday-cc.github.io/ai/assets/images/organizations/reuters.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null,
            "isCached": false
          }
        ],
        "publishers": null,
        "authors": null
      },
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "AI in Healthcare",
        "AI"
      ]
    },
    {
      "path": "_news/2021-12-20-5-artificial-intelligence-stocks-in-cathie-woods-portfolio.md",
      "title": "5 Artificial Intelligence Stocks in Cathie Wood’s Portfolio",
      "excerpt": "(NYSE:TDOC) represented 5.01% of Cathie Wood’s portfolio. In Q3, the company reported revenue of $521.6 million, up 80.6% from the prior-year quarter. Of the 867 hedge funds tracked by Insider Monkey,",
      "sourceUrl": null,
      "webUrl": "https://www.insidermonkey.com/blog/5-artificial-intelligence-stocks-in-cathie-woods-portfolio-1014281/5/",
      "originalUrl": "https://www.insidermonkey.com/blog/5-artificial-intelligence-stocks-in-cathie-woods-portfolio-1014281/5/",
      "featuredContent": null,
      "highlight": null,
      "heat": null,
      "tags": null,
      "images": [
        {
          "url": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2021/03/08164427/Cathie-Wood-ARK-Investment-Management-1267.jpg",
          "width": 1613,
          "height": 2048,
          "title": null,
          "attribution": null,
          "isCached": true
        }
      ],
      "content": "\r\n",
      "type": "article",
      "ampWebUrl": null,
      "cdnAmpWebUrl": null,
      "publishedDateTime": "2021-12-19T11:57:00-08:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Insider Monkey",
        "domain": "insidermonkey.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "AI in Healthcare",
        "AI"
      ]
    },
    {
      "path": "_news/2021-12-19-very-few-things-are-stopping-big-tech-from-popping-in-healthcare.md",
      "title": "Very Few Things Are Stopping Big Tech from “Popping” in Healthcare",
      "excerpt": "Azure Machine Learning and Azure Cognitive Services, to deliver on the vision of the Terra platform at a new level of scale.” Taking a Deep Look at Big Tech’s Influence in Healthcare Big tech companies’ presence in healthcare greatly expanded during ...",
      "sourceUrl": null,
      "webUrl": "https://www.mddionline.com/digital-health/very-few-things-are-stopping-big-tech-“popping”-healthcare",
      "originalUrl": "https://www.mddionline.com/digital-health/very-few-things-are-stopping-big-tech-“popping”-healthcare",
      "featuredContent": null,
      "highlight": null,
      "heat": null,
      "tags": null,
      "images": [
        {
          "url": "https://www.mddionline.com/sites/mddionline.com/files/IMG_Jan112021at22713PM.jpg",
          "width": 770,
          "height": 400,
          "title": null,
          "attribution": null,
          "isCached": true
        }
      ],
      "content": "\r\n",
      "type": "article",
      "ampWebUrl": null,
      "cdnAmpWebUrl": null,
      "publishedDateTime": "2021-12-18T16:00:00-08:00",
      "updatedDateTime": null,
      "provider": {
        "name": "MD&M East",
        "domain": "mddionline.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Microsoft AI",
        "AI",
        "AI in Healthcare"
      ]
    },
    {
      "path": "_news/2021-12-18-computer-vision-in-healthcare-market-overview-by-rising-trends-and-demand-2021-to-2028.md",
      "title": "Computer Vision in Healthcare Market Overview by Rising Trends and Demand 2021 to 2028",
      "excerpt": "Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous ...",
      "sourceUrl": null,
      "webUrl": "https://www.marketwatch.com/press-release/computer-vision-in-healthcare-market-overview-by-rising-trends-and-demand-2021-to-2028-2021-12-17",
      "originalUrl": "https://www.marketwatch.com/press-release/computer-vision-in-healthcare-market-overview-by-rising-trends-and-demand-2021-to-2028-2021-12-17",
      "featuredContent": null,
      "highlight": null,
      "heat": null,
      "tags": null,
      "images": [
        {
          "url": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png",
          "width": 1200,
          "height": 630,
          "title": null,
          "attribution": null,
          "isCached": true
        }
      ],
      "content": "\r\n",
      "type": "article",
      "ampWebUrl": null,
      "cdnAmpWebUrl": null,
      "publishedDateTime": "2021-12-17T08:53:00-08:00",
      "updatedDateTime": null,
      "provider": {
        "name": "MarketWatch",
        "domain": "marketwatch.com",
        "images": [
          {
            "url": "https://everyday-cc.github.io/ai/assets/images/organizations/marketwatch.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null,
            "isCached": false
          }
        ],
        "publishers": null,
        "authors": null
      },
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Computer Vision",
        "AI",
        "AI in Healthcare"
      ]
    },
    {
      "path": "_news/2021-12-16-why-some-psychedelic-assisted-therapy-clinics-are-turning-to-artificial-intelligence-for-digital-mental-therapies.md",
      "title": "Why Some Psychedelic Assisted Therapy Clinics Are Turning To Artificial Intelligence for Digital Mental Therapies",
      "excerpt": "The bottom line: Psychedelic therapy is still in its early days ... evidence-backed protocols and Artificial Intelligence data systems. Geoff Belair, MINDCURE's Chief Technology Officer, said ...",
      "sourceUrl": null,
      "webUrl": "https://www.prnewswire.com/news-releases/why-some-psychedelic-assisted-therapy-clinics-are-turning-to-artificial-intelligence-for-digital-mental-therapies-301446468.html",
      "originalUrl": "https://www.prnewswire.com/news-releases/why-some-psychedelic-assisted-therapy-clinics-are-turning-to-artificial-intelligence-for-digital-mental-therapies-301446468.html",
      "featuredContent": null,
      "highlight": null,
      "heat": null,
      "tags": null,
      "images": null,
      "content": "\r\n",
      "type": "article",
      "ampWebUrl": null,
      "cdnAmpWebUrl": null,
      "publishedDateTime": "2021-12-16T07:48:00-08:00",
      "updatedDateTime": null,
      "provider": {
        "name": "PR Newswire",
        "domain": "prnewswire.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "AI in Healthcare",
        "AI"
      ]
    }
  ],
  "nextPage": null
}